Miasma Theory — 2,300 Years of ‘Bad Air,’ Undone by One Pump Handle in 1854

In the second week of September 1854, John Snow — a London anaesthetist with no laboratory, no microscope finding to show, and no theory the medical establishment accepted — presented the Board of Guardians of St James parish with a hand-drawn map of Soho on which 616 cholera deaths clustered, dot by dot, around a single public water pump on Broad Street, and asked them to remove its handle. The dominant explanation of disease at that moment was more than two millennia old: cholera, plague, malaria and the rest were held to arise from miasma, a poisonous “bad air” exhaled by rotting matter, sewage and stagnant filth. The gap between that doctrine and the dead of Soho was the entire case. The smell hanging over the district was real; the doctrine read it backward. The filth was not poisoning the air — it was leaking, through a cracked cesspit three feet from the well, into the water the neighbourhood drank.

Miasma theory was not a fringe error or a quack’s product. It was the consensus of educated medicine from Hippocrates and Galen through the Victorian sanitary movement, embedded in the architecture of cities, the design of hospitals, and the statutes of public health. The promise of the doctrine was coherence — it explained why disease concentrated in the poorest, foulest, lowest-lying districts. The reality it obscured was the transmission route: contaminated water and, beneath that, a living organism. The cost of the gap was counted in cholera epidemics that swept Britain in 1831–32, 1848–49, 1853–54 and 1866, killing tens of thousands while the responsible institutions fought the smell instead of the supply.

The reversal anchored to Broad Street was neither immediate nor clean. The epidemic was already subsiding when the handle came off on 8 September 1854; Snow himself conceded the attack had peaked days earlier. The parish authorities replaced the handle once the danger passed and rejected his theory. What 1854 produced was not a cure but the first rigorous demonstration that cholera moved through water, not air — reinforced by Snow’s “Grand Experiment” across South London, where homes served by the sewage-fouled Southwark and Vauxhall company died at roughly fourteen times the rate of those served by the cleaner Lambeth supply. Three decades later Robert Koch isolated the comma-shaped bacterium in Calcutta, and the bad air was finally, permanently displaced by the germ.

“Overturned” files this as TH-003 because miasma is the archetype of the displaced idea rather than the fraudulent one: a sincere, universal, internally consistent theory that was simply wrong about mechanism, that resisted its own disproof for a full generation after the decisive evidence arrived, and that yielded only when a confirmed organism replaced the speculative vapour.

The HRT-Prevents-Heart-Disease Doctrine — a 16,608-Woman Trial Halted for Causing the Heart Attacks

On 8 July 2002, the writing group of the Women’s Health Initiative announced that it had stopped the estrogen-plus-progestin arm of its trial roughly three years early, after a mean of 5.2 years, because the combined hormone regimen taken by 16,608 healthy postmenopausal women had increased coronary heart disease rather than preventing it — a hazard ratio of 1.29, alongside elevated stroke (1.41), breast cancer (1.26), and blood clots (roughly doubled). The promise and the reality had been inverted: for nearly two decades, conjugated equine estrogen had been prescribed to protect women’s hearts on the strength of observational data, and the first large randomized test of that promise in healthy women found the hearts were marginally worse off. The gap between the doctrine and the data would be counted in millions of prescriptions written for a benefit that did not exist.

The cardioprotection belief was not a fringe idea. It was mainstream preventive cardiology, taught in medical schools and embedded in clinical guidance, resting on some 40 to 50 observational studies — most prominently the Nurses’ Health Study, which reported current HRT users with coronary heart disease risk reduced by roughly 40 percent (relative risk near 0.61). Conjugated equine estrogen, sold by Wyeth as Premarin since 1942 and as the estrogen-progestin combination Prempro from 1995, exceeded two billion dollars in sales in 2001. The molecules were never recalled; they remain licensed today for menopausal symptoms. What collapsed in July 2002 was the theory attached to them — the claim that they prevented heart disease — displaced not by a scandal or a fraud but by the single most decisive instrument in clinical medicine: a large, randomized, placebo-controlled trial pointed directly at the question the observational data had only ever circled.

The reversal had been foreshadowed. In 1998, the HERS trial — 2,763 women who already had coronary disease, randomized to estrogen-plus-progestin or placebo — had found no overall benefit for secondary prevention, and a 50 percent excess of cardiac events in the first year. The field absorbed HERS as a special case (sick women, late timing) and held to the primary-prevention promise. WHI tested that promise in healthy women, and it failed too. The market answered within months: combined-therapy prescriptions fell by roughly two-thirds within a year, and in 2003 the US Food and Drug Administration imposed a class-wide boxed warning.

This dossier files “Overturned” entry TH-006 as the archetype of a different failure than fraud. No one falsified data. A generation of physicians inferred causation from correlation in self-selected, healthier-than-average hormone users, and only a randomized trial could break the spell — long after the prescription pads had done their work.